Skip to main content

Advertisement

SpringerLink
Log in

One-day or two-day procedure for sentinel node biopsy in melanoma?

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

We compared the outcome of a 1-day and a 2-day sentinel node (SN) biopsy procedure, evaluated in terms of lymphoscintigraphic, surgical and pathological findings.

Methods

We studied 476 patients with melanoma from two melanoma centres using static scintigraphy and blue dye. A proportional odds model was used for statistical analysis.

Results

The number of SNs visualized at scintigraphy increased significantly with time from injection to scintigraphy and activity left in the patient at scintigraphy, and depended on the melanoma location. The number of SNs removed at surgery increased with the number of SNs visualized at scintigraphy and time from injection to surgery. The frequency of nodal metastasis increased with increasing thickness and Clark level of the melanoma, and was highest for two SNs visualized at scintigraphy.

Conclusion

This study showed that early vs. late imaging and surgery do make a difference on the outcome of the SN procedure and confirmed the importance of the scintigraphic visualization of all true SNs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87–97.

    Article  PubMed  CAS  Google Scholar 

  2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.

    PubMed  CAS  Google Scholar 

  3. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, et al. Interval nodes. The forgotten sentinel nodes in patients with melanoma. Arch Surg 2000;135:1168–72.

    Article  PubMed  CAS  Google Scholar 

  4. Lock-Andersen J, Horn J, Sjøstrand H, Nürnberg BM, Stokholm KH. Sentinel node biopsy in cutaneous melanoma. Scand J Plast Reconstr Surg Hand Surg 2006;40:24–31.

    Article  PubMed  Google Scholar 

  5. Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR. Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res 2004;14:521–6.

    Article  PubMed  Google Scholar 

  6. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system, 2nd ed. Cary NC: SAS Institute; 2000.

    Google Scholar 

  7. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;7:13–22.

    Article  Google Scholar 

  8. Lipsitz SR, Kim K, Zhao L. Analysis of repeated categorical data using generalized estimation equation. Stat Med 1994;13:1149–63.

    Article  PubMed  CAS  Google Scholar 

  9. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003;44:570–82.

    PubMed  Google Scholar 

  10. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003;21:43–52.

    Article  PubMed  Google Scholar 

  11. Cook MG, Green MA, Anderson B, Eggermont AM, Ruiter DJ, Spatz A, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314–9.

    Article  PubMed  Google Scholar 

  12. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, Steiniche T. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;100:1683–91.

    Article  PubMed  Google Scholar 

  13. Riber-Hansen R, Sjoegren P, Hamilton-Dutoit SJ, Steiniche T. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload. Ann Surg Oncol 2008;15:1492–501.

    Article  PubMed  Google Scholar 

  14. Uren RF, Howman-Giles R, Thompson JF, Shaw HM, Quinn MJ, O’Brien CJ, et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994;4:395–9.

    Article  PubMed  CAS  Google Scholar 

  15. Ross MI, Reintgen DI. Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases. Eur J Cancer 1998;34(Suppl 3):S7–11.

    Article  PubMed  Google Scholar 

  16. McCarter MD, Yeung H, Yeh S, Fey J, Borgen PI, Cody HS 3rd. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol 2001;8:682–6.

    Article  PubMed  CAS  Google Scholar 

  17. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005;32:286–93.

    Article  PubMed  CAS  Google Scholar 

  18. Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 2005;30:11–5.

    Article  PubMed  Google Scholar 

  19. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, Yoshimoto M, et al. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun 2003;24:663–70.

    Article  PubMed  CAS  Google Scholar 

  20. Goyal A, Douglas-Jones AG, Newcombe RG, Mansel RE. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 2005;11:188–94.

    Article  PubMed  Google Scholar 

  21. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999;6:12–4.

    Article  PubMed  CAS  Google Scholar 

  22. Roaten JB, Pearlman N, Gonzalez R, Gonzalez R, McCarter MD. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma. Arch Surg 2005;140:85–9.

    Article  PubMed  Google Scholar 

  23. Uren RF, Howman-Giles RB, Thompson JF. Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: incidence varies with primary tumor site. Ann Surg Oncol 1998;5:517–21.

    Article  PubMed  CAS  Google Scholar 

  24. McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001;8:192–7.

    Article  PubMed  CAS  Google Scholar 

  25. Klausen TL, Chakera AH, Friis E, Rank F, Heses B, Holm S. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging 2005;25:196–202.

    Article  PubMed  CAS  Google Scholar 

  26. Tanis PJ, van Sandick JW, Nieweg OE, Valdés Olmos RA, Rutgers EJT, Hoefnagel CA, et al. The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging 2002;29:305–11.

    Article  PubMed  CAS  Google Scholar 

  27. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, Nieweg OE, Muller SH, Rutgers EJ, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001;22:579–86.

    Article  PubMed  Google Scholar 

  28. Mariani G, Gipponi M, Moresco L, Villa G, Bartolomei M, Mazzarol G, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 2002;43(6):811–27.

    PubMed  Google Scholar 

  29. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001;42(8):1198–215.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Plastic Surgery and Burns Unit, Section 2102, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark

    A. H. Chakera & K. T. Drzewiecki

  2. Department of Plastic Surgery, Roskilde University Hospital, Roskilde, Denmark

    J. Lock-Andersen

  3. National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark

    U. Hesse

  4. Department of Pathology, Roskilde University Hospital, Roskilde, Denmark

    B. M. Nürnberg

  5. Department of Pathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

    B. R. Juhl

  6. Department of Clinical Physiology and Nuclear Medicine, Roskilde University Hospital, Roskilde, Denmark

    K. H. Stokholm

  7. Department of Clinical Physiology and Nuclear Medicine, PET and Cyclotron Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

    B. Hesse

Authors
  1. A. H. Chakera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Lock-Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Hesse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. M. Nürnberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. R. Juhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. H. Stokholm
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. T. Drzewiecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Hesse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. H. Chakera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakera, A.H., Lock-Andersen, J., Hesse, U. et al. One-day or two-day procedure for sentinel node biopsy in melanoma?. Eur J Nucl Med Mol Imaging 36, 928–937 (2009). https://doi.org/10.1007/s00259-008-1036-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-1036-2

Keywords

Search

Navigation